13 results on '"Alasdair P. Blain"'
Search Results
2. Whole beetroot consumption reduces systolic blood pressure and modulates diversity and composition of the gut microbiota in older participants
- Author
-
Tess E. Capper, David Houghton, Christopher J. Stewart, Alasdair P. Blain, Nicholas McMahon, Mario Siervo, Daniel J. West, and Emma J. Stevenson
- Subjects
Beetroot ,Blood pressure ,Gut microbiota ,Nitrates ,Nutrition. Foods and food supply ,TX341-641 ,Food processing and manufacture ,TP368-456 - Abstract
Background: Age-associated decline in physiological function has been identified as the main factor increasing disease risk, including cardiovascular (CVD) and gastrointestinal tract (GIT) diseases. Nutritional interventions encompassing dietary inorganic nitrates, such as nitrate rich beetroot may reduce the risk for CVD and GIT. Objective: Assess the impact of whole beetroot on blood pressure (BP), microbiota profile and functional measures (physical and bowel). Design: Thirty-six healthy participants were recruited (mean age 67 ± 6 years; body mass index (BMI) 25 ± 2 kg/m2) and assigned randomly to a beetroot (n = 19) or control group (n = 17). Beetroot group consumed 150 g of whole beetroot and a medium-sized banana and the control group consumed a medium-sized banana every second day for 8 weeks. Resting BP, microbiota profiling, physical activity, urinary nitrate, short-chain fatty acids (SCFA) and Bristol Stool Score (BSS) were measured at 0, 4 and 8 weeks. Plasma nitrate was measured at weeks 0 and 8. Results: The beetroot group had a resting systolic BP reduction of 8.0 mmHg (p = 0.03), lower relative abundance of the phyla Bacteroidetes (p = 0.04), and a higher relative abundance of genus Alistipes (p = 0.03), increased Shannon diversity index (p = 0.03), fibre intake of 7 g/day (p
- Published
- 2020
- Full Text
- View/download PDF
3. Analysis of the functional capacity outcome measures for myotonic dystrophy
- Author
-
Aura Cecilia Jimenez‐Moreno, Nikoletta Nikolenko, Marie Kierkegaard, Alasdair P. Blain, Jane Newman, Charlotte Massey, Dionne Moat, Jas Sodhi, Antonio Atalaia, Grainne S. Gorman, Chris Turner, and Hanns Lochmüller
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Objectives Defining clinically relevant outcome measures for myotonic dystrophy type 1 (DM1) that can be valid and feasible for different phenotypes has proven problematic. The Outcome Measures for Myotonic Dystrophy (OMMYD) group proposed a battery of functional outcomes: 6‐minute walk test, 30 seconds sit and stand test, timed 10 m walk test, timed 10 m walk/run test, and nine‐hole peg test. This, however, required a large‐scale investigation, Methods A cohort of 213 patients enrolled in the natural history study, PhenoDM1, was analyzed in cross‐sectional analysis and subsequently 98 patients were followed for longitudinal analysis. We aimed to assess: (1) feasibility and best practice; (2) intra‐session reliability; (3) validity; and (4) behavior over time, of these tests. Results OMMYD outcomes proved feasible as 96% of the participants completed at least one trial for all tests and more than half (n = 113) performed all three trials of each test. Body mass index and disease severity associate with functional capacity. There was a significant difference between the first and second trials of each test. There was a moderate to strong correlation between these functional outcomes and muscle strength, disease severity and patient‐reported outcomes. All outcomes after 1 year detected a change in functional capacity except the nine‐hole peg test. Conclusions These tests can be used as a battery of outcomes or independently based on the shown overlapping psychometric features and strong cross‐correlations. Due to the large and heterogeneous sample of this study, these results can serve as reference values for future studies.
- Published
- 2019
- Full Text
- View/download PDF
4. Cognitive deficits in adult m.3243A>G‐ and m.8344A>G‐related mitochondrial disease: importance of correcting for baseline intellectual ability
- Author
-
Heather L. Moore, Thomas Kelly, Alexandra Bright, Robert H. Field, Andrew M. Schaefer, Alasdair P. Blain, Robert W. Taylor, Robert McFarland, Doug M. Turnbull, and Gráinne S. Gorman
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Objective To determine the cognitive profile of adult patients with mitochondrial disease, and the effect of disease severity on cognition. Methods Using a prospective case‐control design, we compared cognition of patients to normative data and to matched controls, assessed three times over 18 months. Forty‐nine patients with m.3243A>G (N = 36) and m.8344A>G (N = 13) mtDNA mutations and 32 controls, matched by age (±5 years) and premorbid cognition (±10 WTAR FSIQ points), participated. Participants completed neuropsychological assessments of general cognition (WAIS‐IV), executive function (D‐KEFS), and memory (WMS‐IV). Potential predictors of cognition were explored. Results Patients show mild‐to‐moderate premorbid cognitive impairment, but substantial impairment in current general cognition and distinct domains, including verbal comprehension, perceptual reasoning, working memory, processing speed, and memory retrieval. Executive dysfunction may be caused by slower decision‐making. Patients performed worse than controls, except on memory tasks, indicating intact memory, when premorbid cognition is controlled for. Premorbid cognition and disease severity were consistent predictors of cognition in patients; however, cognitive decline appears slow and is unlikely in the short‐term, when other disease‐specific factors remain stable. Interpretation Patients should be monitored to facilitate early identification of a complex profile of cognitive deficits and individuals with higher disease burden should be followed up more closely. On development of cognitive difficulties, appropriate compensatory strategies should be determined through in‐depth assessment. Using strategies such as slower presentation of information, multiple modes of presentation, active discussion to aid understanding and decision‐making, and use of memory aids, may ameliorate difficulties.
- Published
- 2019
- Full Text
- View/download PDF
5. Climate, human behaviour or environment: individual-based modelling of Campylobacter seasonality and strategies to reduce disease burden
- Author
-
Stephen P. Rushton, Roy A. Sanderson, Peter J. Diggle, Mark D. F. Shirley, Alasdair P. Blain, Iain Lake, James A. Maas, William D. K. Reid, Jo Hardstaff, Nicola Williams, Natalia R. Jones, Daniel Rigby, Norval J. C. Strachan, Ken J. Forbes, Paul R. Hunter, Thomas J. Humphrey, and Sarah J. O’Brien
- Subjects
Campylobacter ,Individual-based modelling ,Risk behaviours ,Food ,Weather ,Vaccination ,Medicine - Abstract
Abstract Background With over 800 million cases globally, campylobacteriosis is a major cause of food borne disease. In temperate climates incidence is highly seasonal but the underlying mechanisms are poorly understood, making human disease control difficult. We hypothesised that observed disease patterns reflect complex interactions between weather, patterns of human risk behaviour, immune status and level of food contamination. Only by understanding these can we find effective interventions. Methods We analysed trends in human Campylobacter cases in NE England from 2004 to 2009, investigating the associations between different risk factors and disease using time-series models. We then developed an individual-based (IB) model of risk behaviour, human immunological responses to infection and environmental contamination driven by weather and land use. We parameterised the IB model for NE England and compared outputs to observed numbers of reported cases each month in the population in 2004–2009. Finally, we used it to investigate different community level disease reduction strategies. Results Risk behaviours like countryside visits (t = 3.665, P
- Published
- 2019
- Full Text
- View/download PDF
6. Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues
- Author
-
Chun Chen, PhD, Amy E. Vincent, PhD, Alasdair P. Blain, PhD, Anna L. Smith, Doug M. Turnbull, PhD, FRCP, and Amy K. Reeve, PhD
- Subjects
PD ,mtDNA ,Mitochondrial disease ,POLG mutation ,Neurodegeneration ,Dopaminergic neuron ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Mitochondrial respiratory chain deficiency and mitochondrial DNA deletions are reported in substantia nigra neurons from healthy aged and Parkinson's disease cases, with extensive neuronal loss only seen in the latter. This study aimed to understand the pathological relevance of mitochondrial defects for neuronal survival. Using post-mortem human midbrain, substantia nigra neurons exposed to different types of mitochondrial defects (including mitochondrial DNA point mutations, single and multiple deletions) were compared to neurons from healthy aged and Parkinson's disease cases (either sex) at a single neuronal level. We identified mitochondrial deficiencies in all cases, though these deficiencies were more severe in the mitochondrial disease patients with multiple deletions. A significant reduction in TFAM expression was detected in Parkinson's disease compared to cases with other mitochondrial defects. Higher mitochondrial DNA copy number was detected in healthy aged neurons, despite a deletion level equivalent to Parkinson's disease. Our data support that in individuals with pathogenic mitochondrial defects, neurons respond to mitochondrial defect to survive and such an adaptation may involve TFAM.
- Published
- 2020
- Full Text
- View/download PDF
7. Whole beetroot consumption reduces systolic blood pressure and modulates diversity and composition of the gut microbiota in older participants
- Author
-
Nicholas McMahon, Tess E. Capper, Mario Siervo, Emma J. Stevenson, Christopher J. Stewart, Daniel J. West, Alasdair P. Blain, and David Houghton
- Subjects
0301 basic medicine ,Urinary system ,lcsh:TX341-641 ,Urine ,Gut microbiota ,Gut flora ,law.invention ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Animal science ,Nitrate ,Randomized controlled trial ,law ,Medicine ,Gastrointestinal tract ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Nitrates ,biology ,lcsh:TP368-456 ,business.industry ,biology.organism_classification ,lcsh:Food processing and manufacture ,Blood pressure ,chemistry ,030221 ophthalmology & optometry ,Beetroot ,business ,Body mass index ,lcsh:Nutrition. Foods and food supply ,Food Science - Abstract
Background: Age-associated decline in physiological function has been identified as the main factor increasing disease risk, including cardiovascular (CVD) and gastrointestinal tract (GIT) diseases. Nutritional interventions encompassing dietary inorganic nitrates, such as nitrate rich beetroot may reduce the risk for CVD and GIT. Objective: Assess the impact of whole beetroot on blood pressure (BP), microbiota profile and functional measures (physical and bowel). Design: Thirty-six healthy participants were recruited (mean age 67 ± 6 years; body mass index (BMI) 25 ± 2 kg/m2) and assigned randomly to a beetroot (n = 19) or control group (n = 17). Beetroot group consumed 150 g of whole beetroot and a medium-sized banana and the control group consumed a medium-sized banana every second day for 8 weeks. Resting BP, microbiota profiling, physical activity, urinary nitrate, short-chain fatty acids (SCFA) and Bristol Stool Score (BSS) were measured at 0, 4 and 8 weeks. Plasma nitrate was measured at weeks 0 and 8. Results: The beetroot group had a resting systolic BP reduction of 8.0 mmHg (p = 0.03), lower relative abundance of the phyla Bacteroidetes (p = 0.04), and a higher relative abundance of genus Alistipes (p = 0.03), increased Shannon diversity index (p = 0.03), fibre intake of 7 g/day (p
- Published
- 2020
8. Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
- Author
-
Ashwin Sachdeva, Laura Bone, David McDonald, Gavin Hudson, Andrew Filby, Amy K. Reeve, Douglass M. Turnbull, Sarah J Pickett, Charlotte Warren, Alasdair P. Blain, Amy E. Vincent, Anna L. M. Smith, and Chun Chen
- Subjects
0301 basic medicine ,Parkinson's disease ,Mitochondrial disease ,Disease ,Oxidative phosphorylation ,Biology ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,medicine ,Mass cytometry ,RC346-429 ,Manchester Cancer Research Centre ,ResearchInstitutes_Networks_Beacons/mcrc ,Neurodegeneration ,Dopaminergic ,medicine.disease ,Cellular neuroscience ,Cell biology ,030104 developmental biology ,Neurology ,biology.protein ,Neurology. Diseases of the nervous system ,Neurology (clinical) ,Antibody ,030217 neurology & neurosurgery - Abstract
Here we report the application of a mass spectrometry-based technology, imaging mass cytometry, to perform in-depth proteomic profiling of mitochondrial complexes in single neurons, using metal-conjugated antibodies to label post-mortem human midbrain sections. Mitochondrial dysfunction, particularly deficiency in complex I has previously been associated with the degeneration of dopaminergic neurons in Parkinson’s disease. To further our understanding of the nature of this dysfunction, and to identify Parkinson’s disease specific changes, we validated a panel of antibodies targeting subunits of all five mitochondrial oxidative phosphorylation complexes in dopaminergic neurons from Parkinson’s disease, mitochondrial disease, and control cases. Detailed analysis of the expression profile of these proteins, highlighted heterogeneity between individuals. There is a widespread decrease in expression of all complexes in Parkinson’s neurons, although more severe in mitochondrial disease neurons, however, the combination of affected complexes varies between the two groups. We also provide evidence of a potential neuronal response to mitochondrial dysfunction through a compensatory increase in mitochondrial mass. This study highlights the use of imaging mass cytometry in the assessment and analysis of expression of oxidative phosphorylation proteins, revealing the complexity of deficiencies of these proteins within individual neurons which may contribute to and drive neurodegeneration in Parkinson’s disease.
- Published
- 2021
- Full Text
- View/download PDF
9. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
- Author
-
David Jones, Steven Rushton, Mark Hudson, Jessica K Dyson, Mark D. F. Shirley, and Alasdair P. Blain
- Subjects
medicine.medical_specialty ,AILD, autoimmune liver disease ,Population ,Socio-economic status ,Prevalence ,CFI, comparative fit index ,BECs, biliary epithelial cells ,Geo-epidemiology ,Autoimmune hepatitis ,Disease ,digestive system ,Primary sclerosing cholangitis ,DIC, deviance information criterion ,Environmental health ,Epidemiology ,Internal Medicine ,medicine ,Immunology and Allergy ,Urban ,Rural ,AHSN NENC, Academic Health Science Network for the North East and North Cumbria ,lcsh:RC799-869 ,education ,education.field_of_study ,Hepatology ,SEM, structural equation modelling ,business.industry ,AIH, autoimmune hepatitis ,Primary biliary cholangitis ,Gastroenterology ,SFS, superfund toxic waste site ,RMSEA, root mean square error of association ,medicine.disease ,digestive system diseases ,Social deprivation ,PSC, primary sclerosing cholangitis ,IMD, Index of Multiple Deprivation ,lcsh:Diseases of the digestive system. Gastroenterology ,PBC, primary biliary cholangitis ,Rural area ,business ,Research Article ,Cadmium - Abstract
Background & Aims Autoimmune liver disease (AILD) is thought to result from a complex interplay between genetics and the environment. Studies to date have focussed on primary biliary cholangitis (PBC) and demonstrated higher disease prevalence in more urban, polluted, and socially deprived areas. This study utilises a large cohort of patients with PBC and primary sclerosing cholangitis (PSC) to investigate potential environmental contributors to disease and to explore whether the geo-epidemiology of PBC and PSC are disease-specific or pertain to cholestatic AILD in general. Methods All adult patients with PBC and PSC in a tightly defined geographical area within the UK were identified. Point- and area-based analyses and structural equation modelling (SEM) were used to investigate for disease clustering and examine for relationships between prevalence, distribution of environmental contaminants, and socio-economic status. Results We identified 2,150 patients with PBC and 472 with PSC. Significant spatial clustering was seen for each disease. A high prevalence of PBC was found in urban, post-industrial areas with a strong coal-mining heritage and increased environmental cadmium levels, whereas a high PSC prevalence was found in rural areas and inversely associated with social deprivation. Conclusions This study demonstrates spatial clustering of PBC and PSC and adds to our understanding of potential environmental co-variates for both diseases. Disease clustering, within the same geographical area but over different scales, is confirmed for each disease with distinct risk profiles identified and associations with separate putative environmental factors and socio-economic status. This suggests that different triggers and alternative pathways determine phenotypic expression of autoimmunity in the affected population. Co-variate analysis points towards the existence of specific disease triggers. Lay summary This study looked for potential environmental triggers in patients with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) living in the north-east of England and north Cumbria. We found that PBC was more common in urban areas with a history of coal mining and high levels of cadmium whereas PSC was more common in rural areas with lower levels of social deprivation., Graphical abstract, Highlights • Clustering of PBC and PSC patients occurs with notable geographical differences. • A high prevalence of PBC is seen in urban, post-industrial areas. • PSC is more common in rural areas and inversely associated with social deprivation. • PBC risk is associated with proximity to coal mines and environmental cadmium levels. • Comprehensive epidemiological study can increase understanding of disease aetiology.
- Published
- 2021
10. Supporting a Healthier Takeaway Meal Choice: Creating a Universal Health Rating for Online Takeaway Fast-Food Outlets
- Author
-
Ashley J. Adamson, Jona Danielsen, David Kirk, Louis Goffe, Alasdair P. Blain, Christopher J Dixon, and Nadege Sandrine Uwamahoro
- Subjects
030309 nutrition & dietetics ,Health, Toxicology and Mutagenesis ,lcsh:Medicine ,Sample (statistics) ,Choice Behavior ,Article ,Food Preferences ,03 medical and health sciences ,Traffic signal ,0302 clinical medicine ,Negatively associated ,fast-food ,Food choice ,030212 general & internal medicine ,Marketing ,Meals ,food ordering ,0303 health sciences ,Meal ,lcsh:R ,digestive, oral, and skin physiology ,Public Health, Environmental and Occupational Health ,food literacy ,Nutritional information ,nutrition (or nutritional) literacy ,digital platform ,Generalized linear modelling ,Linear Models ,takeaway ,Fast Foods ,Metric (unit) ,Business ,Diet, Healthy ,Nutritive Value ,human activities - Abstract
Digital food ordering platforms are used by millions across the world and provide easy access to takeaway fast-food that is broadly, though not exclusively, characterised as energy dense and nutrient poor. Outlets are routinely rated for hygiene, but not for their healthiness. Nutritional information is mandatory in pre-packaged foods, with many companies voluntarily using traffic light labels to support making healthier choices. We wanted to identify a feasible universal method to objectively score takeaway fast-food outlets listed on Just Eat that could provide users with an accessible rating that can infer an outlet&rsquo, s &lsquo, healthiness&rsquo, Using a sample of takeaway outlets listed on Just Eat, we obtained four complete assessments by nutrition researchers of each outlet&rsquo, s healthiness to create a cumulative score that ranged from 4 to 12. We then identified and manually extracted nutritional attributes from each outlet&rsquo, s digital menu, e.g., number of vegetables that have the potential to be numerated. Using generalized linear modelling we identified which attributes were linear predictors of an outlet&rsquo, s healthiness assessment from nutritional researchers. The availability of water, salad, and the diversity of vegetables were positively associated with academic researchers&rsquo, assessment of an outlet&rsquo, s healthiness, whereas the availability of chips, desserts, and multiple meal sizes were negatively associated. This study shows promise for the feasibility of an objective measure of healthiness that could be applied to all outlet listings on Just Eat and other digital food outlet aggregation platforms. However, further research is required to assess the metric&rsquo, s validity, its desirability and value to users, and ultimately its potential influence on food choice behaviour.
- Published
- 2020
- Full Text
- View/download PDF
11. Profiling embryonic stem cell differentiation by MALDI-MS: development of a reproducible and robust sample preparation workflow
- Author
-
Greg M. Findlay, Alasdair P. Blain, Anna Segarra Fas, Matthias Trost, and Rachel E. Heap
- Subjects
Matrix-assisted laser desorption/ionization ,Workflow ,Chemistry ,Mammalian cell ,Sample preparation ,Computational biology ,Human cell ,MALDI-TOF Mass Spectrometry ,Embryonic stem cell - Abstract
MALDI TOF mass spectrometry (MS) is widely used to characterize and biotype bacterial samples, but a complimentary method for profiling of mammalian cells is still underdeveloped. Current approaches vary dramatically in their sample preparation methods and are not suitable for high-throughput studies. In this work, we present a universal workflow for mammalian cell MALDI TOF MS analysis and apply it to distinguish ground-state naive and differentiating mouse embryonic stem cells (mESCs), which can be used as a model for drug discovery. We employed a systematic approach testing many parameters to evaluate how efficiently and reproducibly each method extracted unique mass features from four different human cell lines. This data enabled us to develop a unique mammalian cell MALDI TOF workflow involving a freeze-thaw cycle, methanol fixing and CHCA matrix to generate spectra that robustly phenotype different cell lines and are highly reproducible in peak identification across replicate spectra. We applied our optimised workflow to distinguish naive and differentiating populations using multivariate analysis and reproducibly identifying unique features. We were also able to demonstrate the compatibility of our optimised method for current automated liquid handling technologies. Consequently, our MALDI TOF MS profiling method enables identification of unique features and robust phenotyping of mESC differentiation in under 1 hour from culture to analysis, which is significantly faster and cheaper when compared with conventional methods such as qPCR. This method has the potential to be automated and can in the future be applied to profile other cell types and expanded towards cellular MALDI TOF MS screening assays.
- Published
- 2019
- Full Text
- View/download PDF
12. Analysis of the functional capacity outcome measures for myotonic dystrophy
- Author
-
Aura Cecilia Jimenez-Moreno, Dionne Moat, Hanns Lochmüller, Charlotte Massey, Antonio Atalaia, Grainne S. Gorman, Jane Newman, Jas Sodhi, Marie Kierkegaard, Chris Turner, Nikoletta Nikolenko, and Alasdair P. Blain
- Subjects
0301 basic medicine ,Adult ,Male ,medicine.medical_specialty ,Cross-sectional study ,Walk Test ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Myotonic dystrophy ,Severity of Illness Index ,Correlation ,03 medical and health sciences ,0302 clinical medicine ,Severity of illness ,Outcome Assessment, Health Care ,medicine ,Humans ,Myotonic Dystrophy ,Muscle Strength ,RC346-429 ,Research Articles ,2. Zero hunger ,business.industry ,General Neuroscience ,Middle Aged ,medicine.disease ,Test (assessment) ,030104 developmental biology ,Cross-Sectional Studies ,Cohort ,Physical therapy ,Female ,Neurology (clinical) ,Neurology. Diseases of the nervous system ,business ,Body mass index ,030217 neurology & neurosurgery ,Natural history study ,Research Article ,RC321-571 - Abstract
Objectives Defining clinically relevant outcome measures for myotonic dystrophy type 1 (DM1) that can be valid and feasible for different phenotypes has proven problematic. The Outcome Measures for Myotonic Dystrophy (OMMYD) group proposed a battery of functional outcomes: 6‐minute walk test, 30 seconds sit and stand test, timed 10 m walk test, timed 10 m walk/run test, and nine‐hole peg test. This, however, required a large‐scale investigation, Methods A cohort of 213 patients enrolled in the natural history study, PhenoDM1, was analyzed in cross‐sectional analysis and subsequently 98 patients were followed for longitudinal analysis. We aimed to assess: (1) feasibility and best practice; (2) intra‐session reliability; (3) validity; and (4) behavior over time, of these tests. Results OMMYD outcomes proved feasible as 96% of the participants completed at least one trial for all tests and more than half (n = 113) performed all three trials of each test. Body mass index and disease severity associate with functional capacity. There was a significant difference between the first and second trials of each test. There was a moderate to strong correlation between these functional outcomes and muscle strength, disease severity and patient‐reported outcomes. All outcomes after 1 year detected a change in functional capacity except the nine‐hole peg test. Conclusions These tests can be used as a battery of outcomes or independently based on the shown overlapping psychometric features and strong cross‐correlations. Due to the large and heterogeneous sample of this study, these results can serve as reference values for future studies.
- Published
- 2019
13. White kidney bean extract as a nutraceutical: Effects on gut microbiota, alpha-amylase inhibition, and user experiences
- Author
-
David Houghton, Oliver M Shannon, Peter I Chater, Matthew D Wilcox, Jeffrey P Pearson, Kyle Stanforth, Cara Jordan, Leah Avery, Alasdair P Blain, Abraham Joel, Ruth Jeffers, Ruth Nolan, Andrew Nelson, Christopher J Stewart, and Fiona C Malcomson
- Subjects
Nutrition. Foods and food supply ,TX341-641 ,Nutritional diseases. Deficiency diseases ,RC620-627 - Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.